Financial report interval: 2025.12.31 - 2026.03.31
Preview: Ocular Therap(OCUL) predict that the Revenue is 10.79 M (+0.81%), Miss estimate;the EBIT is -93.34 M (-46.03%), Miss estimate;the EPS is -0.4 (-5.26%), Miss estimate.